Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Current Gene Therapy|July 12, 2002
Genetic chemoprotection with mutant O6-alkylguanine-DNA-alkyltransferasesD A Hobin, L J FairbairnBest Practice & Research. Clinical Haematology|April 2, 2002
Prospects for gene therapy using haemopoietic stem cellsL J Fairbairn, J C EwingBone Marrow Transplantation|August 10, 2000
Engineering drug resistance in human cellsL J Fairbairn, J A Rafferty, L S LashfordGene Therapy|January 7, 2006
Human monocytes expressing a CEA-specific chimeric CD64 receptor specifically target CEA-expressing tumour cells in vitro and in vivoA Biglari, T D Southgate, L J Fairbairn, et al.Leukemia|February 13, 2002
Retroviral transfer and expression of human MDR-1 in a murine haemopoietic stem cell line does not alter factor dependence, growth or differentiation characteristicsC M Heyworth, D Gagen, K G Edington, et al.Haematologica|May 9, 2000
The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral productionI Bellantuono, L S Lashford, J A Rafferty, et al.Placenta|August 27, 2005
MDR1 P-gp expression and activity in intact human placental tissue; upregulation by retroviral transductionD E Atkinson, C P Sibley, L J Fairbairn, et al.Bone Marrow Transplantation|August 10, 2000
Genetic modification of haematopoietic cells for combined resistance to podophyllotoxins, other agents covered by MDR1-mediated efflux activity and nitrosoureasC Baum, S Peinert, A Carpinteiro, et al.Cell|September 10, 1993
Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factorsL J Fairbairn, G J Cowling, B M Reipert, et al.Pageof 4